List of Tables
    Table 1. Molecular Diagnostics in Infectious Disease Testing Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Molecular Diagnostics in Infectious Disease Testing Market Trends
    Table 3. Molecular Diagnostics in Infectious Disease Testing Market Drivers
    Table 4. Molecular Diagnostics in Infectious Disease Testing Market Challenges
    Table 5. Molecular Diagnostics in Infectious Disease Testing Market Restraints
    Table 6. Global Molecular Diagnostics in Infectious Disease Testing Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Molecular Diagnostics in Infectious Disease Testing Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Molecular Diagnostics in Infectious Disease Testing Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Molecular Diagnostics in Infectious Disease Testing Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Molecular Diagnostics in Infectious Disease Testing Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Molecular Diagnostics in Infectious Disease Testing Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Molecular Diagnostics in Infectious Disease Testing Revenue Share by Player, 2017-2022
    Table 13. Global Molecular Diagnostics in Infectious Disease Testing Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Molecular Diagnostics in Infectious Disease Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics in Infectious Disease Testing as of 2021)
    Table 15. Top Players of Molecular Diagnostics in Infectious Disease Testing in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Molecular Diagnostics in Infectious Disease Testing Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Molecular Diagnostics in Infectious Disease Testing Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Molecular Diagnostics in Infectious Disease Testing Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Molecular Diagnostics in Infectious Disease Testing Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Molecular Diagnostics in Infectious Disease Testing Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Molecular Diagnostics in Infectious Disease Testing Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Molecular Diagnostics in Infectious Disease Testing Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Molecular Diagnostics in Infectious Disease Testing Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Molecular Diagnostics in Infectious Disease Testing Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Molecular Diagnostics in Infectious Disease Testing Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Molecular Diagnostics in Infectious Disease Testing Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Abbott Company Details
    Table 31. Abbott Business Overview
    Table 32. Abbott Molecular Diagnostics in Infectious Disease Testing Product
    Table 33. Abbott Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million)
    Table 34. Abbott Recent Development
    Table 35. BD Company Details
    Table 36. BD Business Overview
    Table 37. BD Molecular Diagnostics in Infectious Disease Testing Product
    Table 38. BD Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million)
    Table 39. BD Recent Development
    Table 40. BioMerieux Company Details
    Table 41. BioMerieux Business Overview
    Table 42. BioMerieux Molecular Diagnostics in Infectious Disease Testing Product
    Table 43. BioMerieux Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million)
    Table 44. BioMerieux Recent Development
    Table 45. Thermo Fisher Scientific Company Details
    Table 46. Thermo Fisher Scientific Business Overview
    Table 47. Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Product
    Table 48. Thermo Fisher Scientific Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million)
    Table 49. Thermo Fisher Scientific Recent Development
    Table 50. Roche Company Details
    Table 51. Roche Business Overview
    Table 52. Roche Molecular Diagnostics in Infectious Disease Testing Product
    Table 53. Roche Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million)
    Table 54. Roche Recent Development
    Table 55. Siemens Company Details
    Table 56. Siemens Business Overview
    Table 57. Siemens Molecular Diagnostics in Infectious Disease Testing Product
    Table 58. Siemens Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million)
    Table 59. Siemens Recent Development
    Table 60. Veridex Company Details
    Table 61. Veridex Business Overview
    Table 62. Veridex Molecular Diagnostics in Infectious Disease Testing Product
    Table 63. Veridex Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million)
    Table 64. Veridex Recent Development
    Table 65. Luminex Company Details
    Table 66. Luminex Business Overview
    Table 67. Luminex Molecular Diagnostics in Infectious Disease Testing Product
    Table 68. Luminex Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million)
    Table 69. Luminex Recent Development
    Table 70. GenMark Diagnostics Company Details
    Table 71. GenMark Diagnostics Business Overview
    Table 72. GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Product
    Table 73. GenMark Diagnostics Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million)
    Table 74. GenMark Diagnostics Recent Development
    Table 75. Qiagen Company Details
    Table 76. Qiagen Business Overview
    Table 77. Qiagen Molecular Diagnostics in Infectious Disease Testing Product
    Table 78. Qiagen Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million)
    Table 79. Qiagen Recent Development
    Table 80. Genomix Biotech Company Details
    Table 81. Genomix Biotech Business Overview
    Table 82. Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Product
    Table 83. Genomix Biotech Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million)
    Table 84. Genomix Biotech Recent Development
    Table 85. BioTheranostics Company Details
    Table 86. BioTheranostics Business Overview
    Table 87. BioTheranostics Molecular Diagnostics in Infectious Disease Testing Product
    Table 88. BioTheranostics Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million)
    Table 89. BioTheranostics Recent Development
    Table 90. Research Programs/Design for This Report
    Table 91. Key Data Information from Secondary Sources
    Table 92. Key Data Information from Primary Sources
List of Figures
    Figure 1. Molecular Diagnostics in Infectious Disease Testing Product Picture
    Figure 2. Global Molecular Diagnostics in Infectious Disease Testing Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Molecular Diagnostics in Infectious Disease Testing Market Size 2017-2028 (US$ Million)
    Figure 4. United States Molecular Diagnostics in Infectious Disease Testing Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Molecular Diagnostics in Infectious Disease Testing Market Size 2017-2028 (US$ Million)
    Figure 6. United States Molecular Diagnostics in Infectious Disease Testing Market Share in Global 2017-2028
    Figure 7. Molecular Diagnostics in Infectious Disease Testing Report Years Considered
    Figure 8. Product Picture of Polymerase Chain Reaction (PCR)
    Figure 9. Product Picture of Isothermal Nucleic Acid Amplification Technology (INAAT)
    Figure 10. Product Picture of Microarrays
    Figure 11. Product Picture of Next-Generation Sequencing (NGS)
    Figure 12. Product Picture of Hybridization
    Figure 13. Product Picture of Others
    Figure 14. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Type in 2022 & 2028
    Figure 15. Global Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2017-2028) & (US$ Million)
    Figure 16. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Type (2017-2028)
    Figure 17. United States Molecular Diagnostics in Infectious Disease Testing Market Share by Type in 2022 & 2028
    Figure 18. United States Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2017-2028) & (US$ Million)
    Figure 19. United States Molecular Diagnostics in Infectious Disease Testing Market Share by Type (2017-2028)
    Figure 20. Product Picture of Hospitals
    Figure 21. Product Picture of Clinics
    Figure 22. Product Picture of Academic Institutes
    Figure 23. Product Picture of Laboratories
    Figure 24. Product Picture of Others
    Figure 25. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Application in 2022 & 2028
    Figure 26. Global Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2017-2028) & (US$ Million)
    Figure 27. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Application (2017-2028)
    Figure 28. United States Molecular Diagnostics in Infectious Disease Testing Market Share by Application in 2022 & 2028
    Figure 29. United States Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2017-2028) & (US$ Million)
    Figure 30. United States Molecular Diagnostics in Infectious Disease Testing Market Share by Application (2017-2028)
    Figure 31. North America Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 32. U.S. Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Canada Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Europe Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 35. Germany Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. France Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. U.K. Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Italy Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Russia Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 41. China Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Japan Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. South Korea Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. India Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Australia Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Taiwan Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Indonesia Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Thailand Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Malaysia Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Philippines Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Latin America Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 52. Mexico Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Brazil Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Argentina Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 56. Turkey Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Saudi Arabia Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 58. UAE Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Abbott Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
    Figure 60. BD Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
    Figure 61. BioMerieux Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
    Figure 62. Thermo Fisher Scientific Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
    Figure 63. Roche Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
    Figure 64. Siemens Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
    Figure 65. Veridex Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
    Figure 66. Luminex Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
    Figure 67. GenMark Diagnostics Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
    Figure 68. Qiagen Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
    Figure 69. Genomix Biotech Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
    Figure 70. BioTheranostics Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
    Figure 71. Bottom-up and Top-down Approaches for This Report
    Figure 72. Data Triangulation
    Figure 73. Key Executives Interviewed